1. New Obesity Pills Poised to Disrupt Treatment Landscape
Eli Lilly and Novo Nordisk are preparing to launch new oral medications for obesity that are expected to be priced similarly to their blockbuster weight-loss injectables like Wegovy and Zepbound, a notable shift toward increased affordability in this treatment category
2. COVID-19 Cases Rise—But Risk Remains Low for Most
The U.S. is experiencing a midsummer uptick in COVID-19 cases, especially among children. Fortunately, severe illness remains uncommon thanks to existing immunity from past infections and vaccines. However, updated shots targeting a newer variant (LP.8.1) may not be available until mid-September, and their rollout could be limited to high-risk populations.
3. Lifestyle Report: Children’s Health Still Lagging
A new draft report titled Make America Healthy Again highlights persisting issues with poor diets, excessive medication use, and sedentary behavior among children. Notably, it suggests no major reforms to current food and farming policies, raising questions about the report’s effectiveness and impact
4. Innovative Features Enhance Women’s Health Tracking
Oura’s latest app enhancements now include “Pregnancy Insights”—complete with trimester rings, heart rate, temperature monitoring, and emotion tracking—and a “Perimenopause Check-In” tool offering personalized reports for healthcare providers. These features roll out from mid-August 2025 in the U.S. with global availability to follow
5. Health Tech Trend: AI and Wearables Evolve Further
AI Integration in Healthcare continues to expand—from predictive diagnostics to AI-powered clinical documentation, with applications anticipating patterns and freeing up clinician time.
Trinetix
Athenahealth
Franciscan Healthcare
MedPark Hospital
Wearables are becoming more advanced; devices now monitor vitals like blood pressure and blood sugar, not just steps. The global market is expected to reach nearly $70 billion by 2028
6. Gut Health and Personalized Wellness Gain Traction
Interest in gut health—including probiotics and the microbiome—is surging, with more consumers exploring individualized solutions. Meanwhile, preventive and precision medicine—tailoring treatments based on genes and biomarkers—is a growing focus
7. EU Launches the “European Health Data Space”
As of March 26, 2025, the EU’s new regulation allows citizens greater control over their health data and ensures interoperability between systems—empowering researchers, policymakers, and companies to safely access health information for secondary uses
About the Author
